Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer.

Breast Cancer Res Treat · 2024 · PMC11297096 · PMID 38753066

Europe PMC DOI

hedged sentences

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

borderline significancep = 0.064so close (0.05 < p ≤ 0.1)

Although positive PD-L1 (SP142) status before NAC was associated with better recurrence-free survival (RFS) of the patients with borderline significance ( p = 0.064), positive PD-L1 status after NAC was significantly correlated with increased RFS of the patients ( p = 0.043; Fig. 4 ).

also in 7,017 other papers

a decreasing trendno p-value reported

[ 17 ] reported that PD-L1 (SP142)-positive tumor cells, but not PD-L1 (SP142) positive-immune cells showed a decreasing trend after NAC using 22 pairs of TNBC samples.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.